44 results
Page 2 of 3
8-K
EX-99.1
z2dq7a o9nxn0iesg
9 Feb 22
On track to complete the BLA submission in the first half of 2022
7:30am
8-K
EX-99.1
n9y6qek1xid wdm
31 Jan 22
Gamida Cell Provides Key Program Updates and 2022 Financial Guidance
9:00am
8-K
EX-99.1
9cteb sr7lxrkzv
19 Jan 22
Gamida Cell Provides Update on Omidubicel BLA Submission
7:00am
6-K
EX-99.1
6wg300t3
15 Nov 21
Gamida Cell Reports Third Quarter 2021 Financial Results
7:29am
6-K
EX-99.1
oy73mg
12 Nov 21
Gamida Cell Provides Update on Pre-BLA Meeting with FDA for Omidubicel
7:17am
6-K
EX-99.1
9vr9cr0otc9 qg3
26 Oct 21
Gamida Cell to Present NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline and Update on GDA-201 at Today’s Virtual R&D Day
7:30am
6-K
EX-99.1
axrwvnzpb1 1d
13 Aug 21
Report of Foreign Private Issuer
4:04pm
F-3
rpmmw8hzza8
1 Mar 21
Shelf registration (foreign)
4:37pm
424B5
2rk99 esbwwu92evex0
18 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
78v 7lgll33w
17 Dec 20
Prospectus supplement for primary offering
7:53am
6-K
EX-99.1
haczmhif15wjut2oy47r
10 Nov 20
Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update
8:23am
6-K
EX-99.1
j52djsdum
13 Oct 20
Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration
8:21am
6-K
EX-99.1
238s l6s7mq4ao7yw
6 Oct 20
Gamida Cell Announces Positive Topline Data on Secondary Endpoints from Phase 3 Clinical Study of Omidubicel in Patients with Hematologic Malignancies
6:49am
6-K
EX-99.1
obw4p
10 Sep 20
Report of Foreign Private Issuer
3:18pm
6-K
5qzc36ln bmr
12 Aug 20
Report of Foreign Private Issuer
8:27am
6-K
EX-99.3
mgh69o7n0 hdji2k5q
12 Aug 20
Report of Foreign Private Issuer
8:27am
6-K
EX-99.2
2kvnk0 dl2
12 Aug 20
Report of Foreign Private Issuer
8:27am
6-K
EX-99.1
1n8 mtt72
21 May 20
Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update
8:40am
424B5
iu2iqr je
20 May 20
Prospectus supplement for primary offering
4:08pm